Did FDA approve a new sunscreen ingredient?

FDA approves a new sunscreen ingredient for the US

The US Food and Drug Administration (FDA) approved bemotrizinol (also known as BEMT), described as the first new sunscreen ingredient for the US market in more than 25 years. The approval means Americans can access a filtering compound already used in other markets, including Europe and Asia.

Why the approval matters

Sunscreen relies on active ingredients to absorb or block ultraviolet (UV) radiation, helping reduce skin damage from sun exposure. Adding a new ingredient expands the options available to consumers and manufacturers, potentially improving product formulations and choices.

The coverage frames the change as a regulatory milestone—both because it introduces a new active ingredient to the US market and because the timeline is unusually long compared with the pace of other skincare and drug ingredient updates.

What is known from the reporting

• The FDA action expanded the approved list of sunscreen ingredients to include bemotrizinol.
• Bemotrizinol is described as long used outside the US, particularly in Europe and Asia.
• The approval is presented as the first new sunscreen ingredient for the US in roughly a quarter-century.

No additional comparative performance details—such as specific SPF ranges or head-to-head effectiveness versus existing US-approved filters—were provided in the supplied stories.

Overall, the FDA’s decision signals that a widely used non-US filter has cleared US regulatory requirements, giving manufacturers and consumers access to a new option for UV protection.